← All stocks

Entera Bio Ltd.

ENTX Net buying
CIK 0001638097 #3011 in the set updated 21 Sep 2026
Bought (12 mo)
$140.88K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$140.88K
+$140.88K against sales at will

By person

11 insiders · 8 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Germano Geno J
Director
$55.80K (2)
+$55.80K
65,014
$84.52K
+225.1%
Ellis Sean
Director
$34.62K (2)
+$34.62K
208,132
$270.57K
+73.2%
Toledano Miranda Jayne
Chief Executive Officer
$19.91K (1)
+$19.91K
847,135
$1.10M
+260.7%
Rubin Steven D
Director
$19.45K (2)
+$19.45K
34,117
$44.35K
Taitel Haya
Director
$11.10K (1)
+$11.10K
119,269
$155.05K
+105.8%
LIEBERMAN GERALD M
Director
338,454
$439.99K
+33.1%
Burshtein Gregory
Chief of R&D
189,033
$245.74K
+151.6%
Yaacov-Garbeli Dana
Chief Financial Officer
171,441
$222.87K
+97.7%
Galitzer Hillel
Chief Operating Officer
163,566
$212.64K
+154.5%
Malca Yonatan
Director
100,231
$130.30K
+229.7%
OSTROV GERALD M
Director
75,657
$98.35K
+148.5%

No percentages here. This company's share count has moved by a factor of 4.7 over the window, from 36,832,220 to 173,141,831 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 26
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 896,180
History held since 11 Jan 2022